Found: 121
Select item for more details and to access through your institution.
BPI-28592 as a novel second generation inhibitor for NTRK fusion tumors.
- Published in:
- NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00686-8
- By:
- Publication type:
- Article
SAFFRON-104: a phase Ib/II study of sitravatinib alone or with tislelizumab in advanced hepatocellular carcinoma and gastric cancer/gastroesophageal junction cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03806-2
- By:
- Publication type:
- Article
Delivery of CRISPR/Cas9 for therapeutic genome editing.
- Published in:
- Journal of Gene Medicine, 2019, v. 21, n. 7, p. N.PAG, doi. 10.1002/jgm.3107
- By:
- Publication type:
- Article
Aprepitant triple therapy for the prevention of chemotherapy-induced nausea and vomiting following high-dose cisplatin in Chinese patients: a randomized, double-blind, placebo-controlled phase III trial.
- Published in:
- Supportive Care in Cancer, 2014, v. 22, n. 4, p. 979, doi. 10.1007/s00520-013-2043-9
- By:
- Publication type:
- Article
Tumor-suppressive function and mechanism of HOXB13 in right-sided colon cancer.
- Published in:
- Signal Transduction & Targeted Therapy, 2019, v. 4, n. 1, p. N.PAG, doi. 10.1038/s41392-019-0086-1
- By:
- Publication type:
- Article
The role of autophagy in colitis-associated colorectal cancer.
- Published in:
- Signal Transduction & Targeted Therapy, 2018, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41392-018-0031-8
- By:
- Publication type:
- Article
Tislelizumab in Patients with Previously Treated Advanced Hepatocellular Carcinoma (RATIONALE-208): A Multicenter, Non-Randomized, Open-Label, Phase 2 Trial.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 1, p. 72, doi. 10.1159/000527175
- By:
- Publication type:
- Article
Autophagy inhibition sensitizes hepatocellular carcinoma to the multikinase inhibitor linifanib.
- Published in:
- Scientific Reports, 2014, v. 4, n. 1, p. N.PAG, doi. 10.1038/srep06683
- By:
- Publication type:
- Article
Autophagy inhibition sensitizes hepatocellular carcinoma to the multikinase inhibitor linifanib.
- Published in:
- Scientific Reports, 2014, p. 1, doi. 10.1038/srep06683
- By:
- Publication type:
- Article
JNK confers 5-fluorouracil resistance in p53-deficient and mutant p53-expressing colon cancer cells by inducing survival autophagy.
- Published in:
- Scientific Reports, 2014, p. 1, doi. 10.1038/srep04694
- By:
- Publication type:
- Article
RETRACTED ARTICLE: JNK confers 5-fluorouracil resistance in p53-deficient and mutant p53-expressing colon cancer cells by inducing survival autophagy.
- Published in:
- 2014
- By:
- Publication type:
- Correction Notice
The relationship between RAGE gene four common polymorphisms and breast cancer risk in northeastern Han Chinese.
- Published in:
- Scientific Reports, 2014, p. 1, doi. 10.1038/srep04355
- By:
- Publication type:
- Article
The relationship between RAGE gene four common polymorphisms and breast cancer risk in northeastern Han Chinese.
- Published in:
- Scientific Reports, 2014, p. 1, doi. 10.1038/srep04355
- By:
- Publication type:
- Article
NLRP3 and Gut Microbiota Homeostasis: Progress in Research.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 23, p. 3758, doi. 10.3390/cells11233758
- By:
- Publication type:
- Article
Optimizing first-line TKI treatment efficacy in PD-L1-positive EGFR-mutated NSCLC: the impact of antiangiogenic agents.
- Published in:
- Frontiers in Pharmacology, 2024, p. 01, doi. 10.3389/fphar.2024.1391972
- By:
- Publication type:
- Article
Pembrolizumab in Chinese patients with advanced melanoma: 3-year follow-up of the KEYNOTE-151 study.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.882471
- By:
- Publication type:
- Article
Combination treatment of radiofrequency ablation and peptide neoantigen vaccination: Promising modality for future cancer immunotherapy.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.1000681
- By:
- Publication type:
- Article
CD3<sup>+</sup>CD4<sup>-</sup>CD8<sup>-</sup> (Double-Negative) T Cells in Inflammation, Immune Disorders and Cancer.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.816005
- By:
- Publication type:
- Article
Efficacy and Tolerability of Oxycodone Hydrochloride Controlled-Release Tablets in Moderate to Severe Cancer Pain.
- Published in:
- Clinical Drug Investigation, 2007, v. 27, n. 4, p. 259, doi. 10.2165/00044011-200727040-00005
- By:
- Publication type:
- Article
First-in-human study of GFH018, a small molecule inhibitor of transforming growth factor-β receptor I inhibitor, in patients with advanced solid tumors.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12216-7
- By:
- Publication type:
- Article
CSCO ablation expert workshop report: Recommendations for the management of tumor ablation during the coronavirus disease 2019 epidemic.
- Published in:
- 2020
- By:
- Publication type:
- journal article
TRIM59 promotes breast cancer motility by suppressing p62-selective autophagic degradation of PDCD10.
- Published in:
- PLoS Biology, 2018, v. 16, n. 11, p. 1, doi. 10.1371/journal.pbio.3000051
- By:
- Publication type:
- Article
TRIM59 promotes breast cancer motility by suppressing p62-selective autophagic degradation of PDCD10.
- Published in:
- PLoS Biology, 2018, v. 16, n. 11, p. 1, doi. 10.1371/journal.pbio.3000051
- By:
- Publication type:
- Article
Novel Nutrition-Based Nomograms to Assess the Outcomes of Lung Cancer Patients Treated With Anlotinib or Apatinib.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.628693
- By:
- Publication type:
- Article
The Efficacy and Safety of Anlotinib Combined With PD-1 Antibody for Third-Line or Further-Line Treatment of Patients With Advanced Non-Small-Cell Lung Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.619010
- By:
- Publication type:
- Article
Estrogen Receptor Downregulates Expression of PD-1/PD-L1 and Infiltration of CD8<sup>+</sup> T Cells by Inhibiting IL-17 Signaling Transduction in Breast Cancer.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. N.PAG, doi. 10.3389/fonc.2020.582863
- By:
- Publication type:
- Article
Antitumour bioactive peptides isolated from marine organisms.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2017, v. 44, n. 11, p. 1077, doi. 10.1111/1440-1681.12808
- By:
- Publication type:
- Article
Nec-1 Enhances Shikonin-Induced Apoptosis in Leukemia Cells by Inhibition of RIP-1 and ERK1/2.
- Published in:
- International Journal of Molecular Sciences, 2012, v. 13, n. 6, p. 7212, doi. 10.3390/ijms13067212
- By:
- Publication type:
- Article
Safety and efficacy of Pucotenlimab (HX008) - a humanized immunoglobulin G4 monoclonal antibody in patients with locally advanced or metastatic melanoma: a single-arm, multicenter, phase II study.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-022-10473-y
- By:
- Publication type:
- Article
TRIM59 deficiency promotes M1 macrophage activation and inhibits colorectal cancer through the STAT1 signaling pathway.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-66388-0
- By:
- Publication type:
- Article
Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer: The FRESCO Randomized Clinical Trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase Ia dose-escalation trial of Ametumumab (a fully human monoclonal antibody against epidermal growth factor receptor) in patients with advanced solid malignancies.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231165968
- By:
- Publication type:
- Article
Fabrication, microstructure, and optical properties of Tm:Y<sub>3</sub>ScAl<sub>4</sub>O<sub>12</sub> laser ceramics.
- Published in:
- Journal of the American Ceramic Society, 2020, v. 103, n. 3, p. 1819, doi. 10.1111/jace.16873
- By:
- Publication type:
- Article
Fabrication, microstructure, and optical properties of Yb:Y<sub>3</sub>ScAl<sub>4</sub>O<sub>12</sub> transparent ceramics with different doping levels.
- Published in:
- Journal of the American Ceramic Society, 2020, v. 103, n. 1, p. 224, doi. 10.1111/jace.16691
- By:
- Publication type:
- Article
Fabrication and laser operation of Yb:Lu<sub>2</sub>O<sub>3</sub> transparent ceramics from co‐precipitated nano‐powders.
- Published in:
- Journal of the American Ceramic Society, 2019, v. 102, n. 12, p. 7491, doi. 10.1111/jace.16674
- By:
- Publication type:
- Article
Fabrication and properties of Co:MgAl<sub>2</sub>O<sub>4</sub> transparent ceramics for a saturable absorber from coprecipitated nanopowder.
- Published in:
- Journal of the American Ceramic Society, 2019, v. 102, n. 6, p. 3097, doi. 10.1111/jace.16326
- By:
- Publication type:
- Article
Randomised Phase 1b/2 trial of tepotinib vs sorafenib in Asian patients with advanced hepatocellular carcinoma with MET overexpression.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Safety Profile and Adverse Events of Special Interest for Fruquintinib in Chinese Patients with Previously Treated Metastatic Colorectal Cancer: Analysis of the Phase 3 FRESCO Trial.
- Published in:
- Advances in Therapy, 2020, v. 37, n. 11, p. 4585, doi. 10.1007/s12325-020-01477-w
- By:
- Publication type:
- Article
Efficacy and safety of weekly nab-paclitaxel plus gemcitabine in Chinese patients with metastatic adenocarcinoma of the pancreas: a phase II study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Bevacizumab plus capecitabine and cisplatin in Chinese patients with inoperable locally advanced or metastatic gastric or gastroesophageal junction cancer: randomized, double-blind, phase III study (AVATAR study).
- Published in:
- Gastric Cancer, 2015, v. 18, n. 1, p. 168, doi. 10.1007/s10120-014-0351-5
- By:
- Publication type:
- Article
Efficacy, safety and pharmacokinetics of Unecritinib (TQ-B3101) for patients with ROS1 positive advanced non-small cell lung cancer: a Phase I/II Trial.
- Published in:
- Signal Transduction & Targeted Therapy, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41392-023-01454-z
- By:
- Publication type:
- Article
Predictive biomarkers for tumor immune checkpoint blockade.
- Published in:
- Cancer Management & Research, 2018, v. 10, p. 4501, doi. 10.2147/CMAR.S179680
- By:
- Publication type:
- Article
A phase 1 trial of fuzuloparib in combination with apatinib for advanced ovarian and triple-negative breast cancer: efficacy, safety, pharmacokinetics and germline BRCA mutation analysis.
- Published in:
- BMC Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12916-023-03046-8
- By:
- Publication type:
- Article
Analysis of potential genes and pathways associated with the colorectal normal mucosa–adenoma–carcinoma sequence.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 6, p. 2555, doi. 10.1002/cam4.1484
- By:
- Publication type:
- Article
Medical Cannabinoids for Cancer Cachexia: A Systematic Review and Meta-Analysis.
- Published in:
- BioMed Research International, 2019, p. 1, doi. 10.1155/2019/2864384
- By:
- Publication type:
- Article
An oxidative stress biomarkers predict prognosis in gastric cancer patients receiving immune checkpoint inhibitor.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1173266
- By:
- Publication type:
- Article
Combined with prognostic nutritional index and IgM for predicting the clinical outcomes of gastric cancer patients who received surgery.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1113428
- By:
- Publication type:
- Article
A multi-center effectiveness comparison study of fruquintinib with constructed external control cohort of other targeted kinase inhibitors using realworld data in third-line treatment of metastatic colorectal cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1044328
- By:
- Publication type:
- Article
Genetic effect of metformin use on risk of cancers: evidence from Mendelian randomization analysis.
- Published in:
- Diabetology & Metabolic Syndrome, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13098-023-01218-3
- By:
- Publication type:
- Article
Use of Metformin Alone Is Not Associated with Survival Outcomes of Colorectal Cancer Cell but AMPK Activator AICAR Sensitizes Anticancer Effect of 5-Fluorouracil through AMPK Activation.
- Published in:
- PLoS ONE, 2014, v. 9, n. 5, p. 1, doi. 10.1371/journal.pone.0097781
- By:
- Publication type:
- Article